At Dexcel, we believe that strong manufacturing capabilities are part
of our core business. All our sites use state of the art equipment and
are highly automated in order to ensure the highest level of quality.


Dexcel manufacturing facilities employ cutting-edge,
computer-controlled technologies, including electronic batch
recording, automated warehousing, end of line automation and more.
This facilitates optimization of production and reduces human error.


Our global supply chain management and responsive service ensure
consistency, competitive pricing, timely delivery and efficient
inventory control.


All our production sites are approved by the FDA and EMA and are operating according to cGMP standards.

We enjoy an excellent track record with regulatory authorities, partners, and customers.

Manufacturing Capabilities

Dexcel specializes in the manufacturing of modified release Oral Solid Dosage products. Our facilities operate 24 hours a day and have a combined manufacturing capacity of over 5 billion units per year.

Manufacturing and R&D Sites

Our bulk manufacturing site in

Yokneam is highly automated and was

specially designed for efficient

manufacturing of high volume products.

Or Akiva

Our campus in Or Akiva is designed for mid volume products, including state of the art packaging and QC facilities. Dexcel’s headquarters are located in Or Akiva.


Our Jerusalem site is designed for the

production of low volume, specialty

products and also serves as an R&D center.

No manufacturing in Jerusalem to date.